blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3161139

EP3161139 - APTAMERS SPECIFIC FOR TLR-4 AND USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.05.2021
Database last updated on 26.03.2026
FormerThe patent has been granted
Status updated on  19.06.2020
FormerGrant of patent is intended
Status updated on  19.05.2020
FormerExamination is in progress
Status updated on  11.05.2020
FormerGrant of patent is intended
Status updated on  09.01.2020
FormerExamination is in progress
Status updated on  17.12.2019
FormerGrant of patent is intended
Status updated on  06.08.2019
FormerExamination is in progress
Status updated on  19.01.2018
FormerRequest for examination was made
Status updated on  31.03.2017
FormerThe international publication has been made
Status updated on  23.01.2017
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024  [2024/41]
Applicant(s)For all designated states
Aptatargets, S.L.
Avenida Cardenal Herrera Oria 298 - 1ª Planta
Despacho 4
28035 Madrid / ES
[2017/50]
Former [2017/18]For all designated states
Aptus Biotech, S.L.
Campus de Cantoblanco
Faraday 7
28049 Madrid / ES
Inventor(s)01 / LIZASOAIN HERNÁNDEZ, Ignacio
Conde de Cartagena 5 - 9ºC
E-28007 Madrid / ES
02 / GONZÁLEZ MUÑOZ, Víctor Manuel
Peña Marcos 62
E-28490 Becerril de la Sierra - Madrid / ES
03 / FERNÁNDEZ GÓMEZ-CHACÓN, Gerónimo
Aptus Biotech, S.L.
Avenida Cardenal Herrera Oria 298 - 1ª Planta
Despacho 4
E-28035 Madrid / ES
04 / MORO SÁNCHEZ, María Ángeles
Conde de Cartagena 5 - 9ºC
E-28007 Madrid / ES
05 / MARTÍN PALMA, Mª Elena
Plaza de Las Américas 5 - 2ºD
E-28770 Colmenar Viejo / ES
06 / MORAGA YÉBENES, Ana
Francisco García Pavón 42 - 3ºH
E-13700 Tomelloso - Ciudad Real / ES
 [2017/51]
Former [2017/18]01 / LIZASOAIN HERNÁNDEZ, Ignacio
Conde de Cartagena 5 - 9ºC
E-28007 Madrid / ES
02 / GONZÁLEZ MUÑOZ, Víctor Manuel
Peña Marcos 62
E-28490 Becerril de la Sierra - Madrid / ES
03 / FERNÁNDEZ GÓMEZ-CHACÓN, Gerónimo
Faraday 7
Campus Cantoblanco
E-28049 Madrid / ES
04 / MORO SÁNCHEZ, María Ángeles
Conde de Cartagena 5 - 9ºC
E-28007 Madrid / ES
05 / MARTÍN PALMA, Mª Elena
Plaza de Las Américas 5 - 2ºD
E-28770 Colmenar Viejo / ES
06 / MORAGA YÉBENES, Ana
Francisco García Pavón 42 - 3ºH
E-13700 Tomelloso - Ciudad Real / ES
Representative(s)ABG Intellectual Property Law, S.L.
Avenida de Burgos, 16D
Edificio Euromor
28036 Madrid / ES
[2020/30]
Former [2017/18]ABG Patentes, S.L.
Avenida de Burgos, 16D
Edificio Euromor
28036 Madrid / ES
Application number, filing date15732619.024.06.2015
[2017/18]
WO2015EP64277
Priority number, dateES2014003095524.06.2014         Original published format: ES 201430955
[2017/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015197706
Date:30.12.2015
Language:EN
[2015/52]
Type: A1 Application with search report 
No.:EP3161139
Date:03.05.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 30.12.2015 takes the place of the publication of the European patent application.
[2017/18]
Type: B1 Patent specification 
No.:EP3161139
Date:22.07.2020
Language:EN
[2020/30]
Search report(s)International search report - published on:EP30.12.2015
ClassificationIPC:C12N15/115, A61P29/00, A61K31/7088
[2017/18]
CPC:
C12N15/115 (EP,CN,ES,KR,RU,US); A61P29/00 (EP,RU); A61K31/7088 (EP,CN,KR,US);
A61K45/06 (CN); A61K48/005 (CN); A61K49/0013 (CN);
A61K49/04 (CN); A61K51/00 (CN); A61P19/02 (EP);
A61P25/00 (EP); A61P25/30 (EP); A61P25/36 (EP);
A61P27/02 (EP); A61P31/04 (EP); A61P37/02 (EP);
A61P43/00 (EP); A61P9/00 (EP); A61P9/10 (EP);
C12N15/1138 (ES); G01N33/566 (US); G01N33/68 (CN);
G01N33/6893 (KR); C12N2310/16 (EP,CN,KR,US); C12N2310/53 (EP,CN,KR,US);
G01N2333/705 (KR); G01N2333/70596 (US); G01N2800/164 (KR);
G01N2800/2871 (KR) (-)
C-Set:
A61K31/7088, A61K2300/00 (CN)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/18]
Extension statesBA23.01.2017
ME23.01.2017
Validation statesMA23.01.2017
TitleGerman:TLR-4-SPEZIFISCHE APTAMERE UND VERWENDUNGEN DAVON[2017/18]
English:APTAMERS SPECIFIC FOR TLR-4 AND USES THEREOF[2017/18]
French:APTAMÈRES SPÉCIFIQUES DU RÉCEPTEUR TLR-4 ET LEURS UTILISATIONS[2017/18]
Entry into regional phase23.01.2017National basic fee paid 
23.01.2017Designation fee(s) paid 
23.01.2017Examination fee paid 
Examination procedure23.01.2017Amendment by applicant (claims and/or description)
23.01.2017Examination requested  [2017/18]
23.01.2017Date on which the examining division has become responsible
19.01.2018Despatch of a communication from the examining division (Time limit: M06)
16.07.2018Reply to a communication from the examining division
28.08.2018Despatch of a communication from the examining division (Time limit: M06)
06.03.2019Reply to a communication from the examining division
07.08.2019Communication of intention to grant the patent
13.12.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
10.01.2020Communication of intention to grant the patent
05.05.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
05.05.2020Fee for grant paid
05.05.2020Fee for publishing/printing paid
19.05.2020Information about intention to grant a patent
19.05.2020Receipt of the translation of the claim(s)
Opposition(s)23.04.2021No opposition filed within time limit [2021/26]
Fees paidRenewal fee
03.04.2017Renewal fee patent year 03
07.06.2018Renewal fee patent year 04
13.06.2019Renewal fee patent year 05
11.06.2020Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU24.06.2015
AL22.07.2020
CY22.07.2020
EE22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
MK22.07.2020
MT22.07.2020
RO22.07.2020
RS22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
GR23.10.2020
IS22.11.2020
[2024/41]
Former [2024/22]HU24.06.2015
AL22.07.2020
CY22.07.2020
EE22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
MK22.07.2020
RO22.07.2020
RS22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
GR23.10.2020
IS22.11.2020
Former [2023/30]HU24.06.2015
AL22.07.2020
CY22.07.2020
EE22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
RO22.07.2020
RS22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
GR23.10.2020
IS22.11.2020
Former [2023/27]HU24.06.2015
AL22.07.2020
EE22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
RO22.07.2020
RS22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
GR23.10.2020
IS22.11.2020
Former [2022/08]AL22.07.2020
EE22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
MC22.07.2020
RO22.07.2020
RS22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
GR23.10.2020
IS22.11.2020
Former [2021/28]AL22.07.2020
EE22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
RO22.07.2020
RS22.07.2020
SK22.07.2020
SM22.07.2020
BG22.10.2020
GR23.10.2020
IS22.11.2020
Former [2021/25]AL22.07.2020
EE22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
RO22.07.2020
RS22.07.2020
SM22.07.2020
BG22.10.2020
GR23.10.2020
IS22.11.2020
Former [2021/22]EE22.07.2020
HR22.07.2020
LT22.07.2020
LV22.07.2020
RO22.07.2020
RS22.07.2020
SM22.07.2020
BG22.10.2020
GR23.10.2020
IS22.11.2020
Former [2021/10]HR22.07.2020
LT22.07.2020
LV22.07.2020
RS22.07.2020
BG22.10.2020
GR23.10.2020
IS22.11.2020
Former [2021/07]LT22.07.2020
Cited inInternational search[AD] WO2006138681  (UNIV ROCHESTER et al.) [AD] 1-25 * the whole document *
 [A] WO2010060030  (UNIV ARIZONA et al.) [A] 1-25 * the whole document *
 [A] WO2010053975  (IDERA PHARMACEUTICALS INC et al.) [A] 1-25 * the whole document *
 [A] WO2008076804  (UNIV CASE WESTERN RESERVE et al.) [A] 1-25 * the whole document *
 [A]   MONA HEDAYAT ET AL: "Prophylactic and therapeutic implications of toll-like receptor ligands", MEDICINAL RESEARCH REVIEWS, vol. 32, no. 2, 25 October 2010 (2010-10-25), pages 294 - 325, XP055039310, ISSN: 0198-6325, DOI: 10.1002/med.20214 [A] 1-25 * the whole document *

DOI:   http://dx.doi.org/10.1002/med.20214
 [A]   X. WITTEBOLE ET AL: "Toll-like Receptor 4 Modulation as a Strategy to Treat Sepsis", MEDIATORS OF INFLAMMATION, vol. 2010, 14 April 2010 (2010-04-14), pages 1 - 9, XP055039312, ISSN: 0962-9351, DOI: 10.1155/2010/568396 [A] 1-25 * the whole document *

DOI:   http://dx.doi.org/10.1155/2010/568396
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.